1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Medical Aesthetic Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Medical Aesthetic Devices Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Medical Aesthetic Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Aesthetic Laser & Energy Devices
6.3.1.1. Ablatives Skin Resurfacing Devices
6.3.1.2. Non-ablative Skin Resurfacing Devices
6.3.2. Skin Tightening & Body Contouring Devices
6.3.2.1. Liposuction Devices
6.3.2.2. Skin Tightening Devices
6.3.2.3. Cellulite Reduction Devices
6.3.3. Aesthetic Implants
6.3.3.1. Breast Implants
6.3.3.2. Soft Tissue Implants
6.3.3.3. Aesthetic Dental Implants
6.3.3.4. Others
6.3.4. Facial Aesthetic Devices
6.3.4.1. Microdermabrasion Devices
6.3.4.2. Botulinum Toxin
6.3.4.3. Dermal Fillers
6.4. Market Attractiveness Analysis, by Product Type
7. Global Medical Aesthetic Devices Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Facial & Body Contouring
7.3.2. Facial & Skin Rejuvenation
7.3.3. Breast Enhancement
7.3.4. Scar Treatment
7.3.5. Reconstructive Surgery
7.3.6. Tattoo Removal
7.3.7. Hair Removal
7.4. Market Attractiveness Analysis, by Application
8. Global Medical Aesthetic Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Dermatology Clinics
8.3.3. Cosmetic Centers
8.4. Market Attractiveness Analysis, by Application
9. Global Medical Aesthetic Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Medical Aesthetic Devices Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2017–2031
10.3.1. Aesthetic Laser & Energy Devices
10.3.1.1. Ablatives Skin Resurfacing Devices
10.3.1.2. Non-ablative Skin Resurfacing Devices
10.3.2. Skin Tightening & Body Contouring Devices
10.3.2.1. Liposuction Devices
10.3.2.2. Skin Tightening Devices
10.3.2.3. Cellulite Reduction Devices
10.3.3. Aesthetic Implants
10.3.3.1. Breast Implants
10.3.3.2. Soft Tissue Implants
10.3.3.3. Aesthetic Dental Implants
10.3.3.4. Others
10.3.4. Facial Aesthetic Devices
10.3.4.1. Microdermabrasion Devices
10.3.4.2. Botulinum Toxin
10.3.4.3. Dermal Fillers
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Facial & Body Contouring
10.4.2. Facial & Skin Rejuvenation
10.4.3. Breast Enhancement
10.4.4. Scar Treatment
10.4.5. Reconstructive Surgery
10.4.6. Tattoo Removal
10.4.7. Hair Removal
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Dermatology Clinics
10.5.3. Cosmetic Centers
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Medical Aesthetic Devices Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2017–2031
11.3.1. Aesthetic Laser & Energy Devices
11.3.1.1. Ablatives Skin Resurfacing Devices
11.3.1.2. Non-ablative Skin Resurfacing Devices
11.3.2. Skin Tightening & Body Contouring Devices
11.3.2.1. Liposuction Devices
11.3.2.2. Skin Tightening Devices
11.3.2.3. Cellulite Reduction Devices
11.3.3. Aesthetic Implants
11.3.3.1. Breast Implants
11.3.3.2. Soft Tissue Implants
11.3.3.3. Aesthetic Dental Implants
11.3.3.4. Others
11.3.4. Facial Aesthetic Devices
11.3.4.1. Microdermabrasion Devices
11.3.4.2. Botulinum Toxin
11.3.4.3. Dermal Fillers
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Facial & Body Contouring
11.4.2. Facial & Skin Rejuvenation
11.4.3. Breast Enhancement
11.4.4. Scar Treatment
11.4.5. Reconstructive Surgery
11.4.6. Tattoo Removal
11.4.7. Hair Removal
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Dermatology Clinics
11.5.3. Cosmetic Centers
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Medical Aesthetic Devices Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2017–2031
12.3.1. Aesthetic Laser & Energy Devices
12.3.1.1. Ablatives Skin Resurfacing Devices
12.3.1.2. Non-ablative Skin Resurfacing Devices
12.3.2. Skin Tightening & Body Contouring Devices
12.3.2.1. Liposuction Devices
12.3.2.2. Skin Tightening Devices
12.3.2.3. Cellulite Reduction Devices
12.3.3. Aesthetic Implants
12.3.3.1. Breast Implants
12.3.3.2. Soft Tissue Implants
12.3.3.3. Aesthetic Dental Implants
12.3.3.4. Others
12.3.4. Facial Aesthetic Devices
12.3.4.1. Microdermabrasion Devices
12.3.4.2. Botulinum Toxin
12.3.4.3. Dermal Fillers
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Facial & Body Contouring
12.4.2. Facial & Skin Rejuvenation
12.4.3. Breast Enhancement
12.4.4. Scar Treatment
12.4.5. Reconstructive Surgery
12.4.6. Tattoo Removal
12.4.7. Hair Removal
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Dermatology Clinics
12.5.3. Cosmetic Centers
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Medical Aesthetic Devices Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2017–2031
13.3.1. Aesthetic Laser & Energy Devices
13.3.1.1. Ablatives Skin Resurfacing Devices
13.3.1.2. Non-ablative Skin Resurfacing Devices
13.3.2. Skin Tightening & Body Contouring Devices
13.3.2.1. Liposuction Devices
13.3.2.2. Skin Tightening Devices
13.3.2.3. Cellulite Reduction Devices
13.3.3. Aesthetic Implants
13.3.3.1. Breast Implants
13.3.3.2. Soft Tissue Implants
13.3.3.3. Aesthetic Dental Implants
13.3.3.4. Others
13.3.4. Facial Aesthetic Devices
13.3.4.1. Microdermabrasion Devices
13.3.4.2. Botulinum Toxin
13.3.4.3. Dermal Fillers
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Facial & Body Contouring
13.4.2. Facial & Skin Rejuvenation
13.4.3. Breast Enhancement
13.4.4. Scar Treatment
13.4.5. Reconstructive Surgery
13.4.6. Tattoo Removal
13.4.7. Hair Removal
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Dermatology Clinics
13.5.3. Cosmetic Centers
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Medical Aesthetic Devices Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2017–2031
14.3.1. Aesthetic Laser & Energy Devices
14.3.1.1. Ablatives Skin Resurfacing Devices
14.3.1.2. Non-ablative Skin Resurfacing Devices
14.3.2. Skin Tightening & Body Contouring Devices
14.3.2.1. Liposuction Devices
14.3.2.2. Skin Tightening Devices
14.3.2.3. Cellulite Reduction Devices
14.3.3. Aesthetic Implants
14.3.3.1. Breast Implants
14.3.3.2. Soft Tissue Implants
14.3.3.3. Aesthetic Dental Implants
14.3.3.4. Others
14.3.4. Facial Aesthetic Devices
14.3.4.1. Microdermabrasion Devices
14.3.4.2. Botulinum Toxin
14.3.4.3. Dermal Fillers
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Facial & Body Contouring
14.4.2. Facial & Skin Rejuvenation
14.4.3. Breast Enhancement
14.4.4. Scar Treatment
14.4.5. Reconstructive Surgery
14.4.6. Tattoo Removal
14.4.7. Hair Removal
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Dermatology Clinics
14.5.3. Cosmetic Centers
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Alma Lasers
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. AbbVie Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Cutera, Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Hologic, Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Lumenis Ltd.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Mentor Worldwide LLC (Johnson & Johnson)
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Solta Medical, Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Candela Corporation
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Merz Pharma GmbH & Co. KGaA
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer